Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FRO | RMBS |
|---|---|---|
| Price | $53.75 | $110.30 |
| Change today | ▲ 1.92% | ▼ 1.49% |
| Market cap | $11.97B | $11.96B |
| Return, 3 months | +52.3% | +4.1% |
| Return, year to date | +183.1% | +20.0% |
| Return, 1 year | +168.8% | +9.2% |
| P/E (TTM) | 8.1 | 50.6 |
| P/B | 3.8 | 8.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 5.82% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 77 | 67 |
| 30-day volatility | 36.7% | 59.6% |
| Max drawdown, 1 year | -21.4% | -52.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
